Interactive Tool to Guide Management of Adverse Events With BTK Inhibitor Therapy in Hematologic Malignancies

Content Format:

Tool

Credit Type:

--

Credits:

--
Independent Conference Highlights of the 2024 EHA Congress: Spotlight on Mantle Cell Lymphoma

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Key Updates in Mantle Cell Lymphoma From the 2024 EHA Congress

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Independent Conference Highlights of the 2024 EHA Congress: Spotlight on Mantle Cell Lymphoma

Content Format:

Slideset

Credit Type:

--

Credits:

--
Expert Guidance for the Treatment of CLL: An International Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
Applying Data to Practice: BTK Inhibitor Therapies to Treat CLL and MCL

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Key Updates With BTK Inhibitors in CLL and MCL From SOHO 2023

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

0.50
New Evidence With BTK Inhibitor Therapy in CLL and MCL From SOHO 2023

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Key Updates With BTK Inhibitors in MCL From ICML 2023

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

0.50
New Evidence With BTK Inhibitor Therapy in MCL From ICML 2023

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Interactive Tool for Managing BTK Inhibitor−Associated AEs in Hematologic Malignancies: A Global Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
Key Updates With BTK Inhibitors in CLL From EHA 2023

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

0.50
New Evidence With BTK Inhibitor Therapy in CLL From EHA 2023

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Targeted Therapeutics in CLL and MCL: Applying Emerging BTK Inhibitor Therapy Data to Practice

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

0.25
2023 Global Conference Coverage Updates on BTK Inhibitors for CLL and MCL

Content Format:

Slideset

Credit Type:

--

Credits:

--
Expert Guidance for the Treatment of CLL: An International Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
BTK Inhibitor Therapy for Patients With CLL: A Global Perspective

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Perspectiva global sobre los datos de tratamientos emergentes con inhibidores de TQB para LLC y LCM en recidiva/refractarios en 2022

Content Format:

Text Module

Credit Type:

--

Credits:

--
Uma perspectiva global sobre os dados emergentes da terapia com inibidor de BTK para LLC e LCM recidivantes/refratários em 2022

Content Format:

Text Module

Credit Type:

--

Credits:

--
Une perspective globale sur les données émergentes relatives à la thérapie par inhibiteurs BTK chez les patients atteints de LLC ou du LCM récidivant/réfractaire en 2022

Content Format:

Text Module

Credit Type:

--

Credits:

--
A Global Perspective on Emerging BTK Inhibitor Therapy Data for Relapsed/Refractory CLL and MCL in 2022

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
International Experts Address HCP Questions on BTK Inhibitors for CLL and MCL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
International Experts Address HCP Questions on BTK Inhibitors for CLL and MCL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
International Experts Address HCP Questions on BTK Inhibitors for CLL and MCL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
A Global Perspective on Emerging BTK Inhibitor Therapy Data for CLL and MCL

Content Format:

Multimedia

Credit Type:

--

Credits:

--
International Experts Address HCP Questions on BTK Inhibitors for CLL and MCL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--